iS Clinical launch Sheald post-procedure kit

Thursday, 17 April 2014 News

iS Clinical have launched a new kit to aid the healing process of post-procedure/treatment skin. 

The kit aims to hydrate the skin whilst creating an antimicrobial barrier, in order to sooth sensitive skin and aid it in recovery from ablative procedures such as fractional and CO2 laser skin resurfacing and deep chemical peels. 

New website provides support for the aftermath of acne

Friday, 11 April 2014 News

This week saw the launch of a new acne scar resource website aimed at providing support and resources for people suffering with acne scarring. Launched in Canada, Ascarfreeme.ca seeks to help people manage the emotional and physical impacts of acne scarring. 

The website offers users a wealth of online resources, from articles on the latest treatments to blog posts on improving self-esteem, whilst also providing members with a platform on which to share their experiences via community message boards.

Research suggests glycemic index of food can influence acne severity

Friday, 11 April 2014 News

New research has shown that young adults with moderate to severe acne have reported consuming food containing more sugar and dairy, and with a higher glycemic index, than those with minimal acne.

The study included 248 volunteers aged 18 to 25 years old. They reported on the severity of their acne, what they ate each day, and what foods they thought may exacerbate their acne.

Study converts adult human cells to hair follicle generating stem cells

Wednesday, 09 April 2014 News

Researchers from the Perelman School of Medicine at the University of Pennsylvania have published results of a study describing how they were able to convert adult stem cells into epithelial stem cells (EpSCs).

When implanted into immunocompromised mice, the EpSCs regenerated the different cell types of human skin and hair follicles, and even produced structurally recognizable hair shaft, raising the possibility that they may eventually enable hair regeneration in people.

Fat dissolving injection trials show positive results

Monday, 07 April 2014 News

The US phase 3 trials of new fat dissolving injectable ATX-101 developed by US biopharmaceutical company Kythera have shown statistically significant reductions in submental fat (double chin).

The results of the trials were presented by Dr Jean Curruthers at the annual meeting of the American Society for Dermatologic Surgery. Two studies of more than 1,000 patients with moderate to severe submental fat were conducted with patients having up to six treatments at roughly one month intervals. Approximately half had all six injections, with 70.3% and 66.9% showing a clinically meaningful improvement in the first and second trials respectively.

Lumenis launches LightSheer INFINITY and LightSheer DESIRE

Friday, 04 April 2014 News

Lumenis have launched the LightSheer INFINITY and LightSheer DESIRE laser hair reduction products at the Anti-Aging Medicine World Congress, currently taking place in Monte-Carlo, Monaco. 

The new products, launched on April 3, incorporate Lumenis’ proprietary HIT (High-Speed Integrated Technology) and ChillTip technologies, with aims to increase efficacy and patient comfort. 

Allergan Year of the Eye: Part 2

Friday, 04 April 2014 Features

ALLERGAN REVEALS ITS NEW TREATMENT PROTOCOL FOR TOTAL EYE AREA REVITALIZATION

Dr Raj Acquilla, who helped develop the new protocol, discusses patient selection, offers further tips on technique and shares his results

I have been involved in training delegates in periorbital injection techniques using the Juvederm filler portfolio over the last four years. The subsequent development in Vycross technology provided the perfect solution for volume correction and lift in this delicate anatomical region. After producing the first tear trough injection strategy, I was given the opportunity to lead the first large scale tear trough study in France alongside Allergan key opinion leaders. This was the foundation for my periorbital injection protocol. To accompany the protocol, we have also filmed an injection video which will be available via the Allergan Facial Anatomy App.

Allergan Year of the Eye: Part 1

Friday, 04 April 2014 Features

Allergan reveals its new treatment protocol for total eye area revitalization

Mr Taimur Shoaib, faculty member of the Allergan Medical Institute, discusses the treatment protocol and the training on offer

2014 has been dubbed ‘the year of the eye’ by Allergan, and at the 12th Anti-Aging Medicine World Congress in Monte-Carlo this April, the company will launch a unique new treatment protocol for the periorbital area. Designed to rejuvenate the entire area, safely, effectively and using scientifically proven techniques, this combination approach of botulinum toxin and dermal filler treatments was developed in consultation with twelve leading medical aesthetics practitioners from across Europe. It brings a holistic, individualized and stepwise approach to revitalization of this most delicate, expressive and important area of the face. A training programme in how to use the new protocol will now be rolled out to over to over 15,000 medical practitioners across Europe.

Advertising

Since its launch in 2009 the Aesthetics journal, formerly Cosmetic News, has become the leading monthly journal for medical aesthetic professionals in the UK.

To find out more about opportunities for your business please call our Sales Manager Hollie Dunwell.

Tel: 01268 754 897

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Contact Us

Aesthetics

Synaptiq House
6 Canaan Lane
Edinburgh
EH10 4SY

Tel: 01268 754 897  
Fax: 0131 447 2075

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Aesthetics | Tel: 01268 754 897 Fax: 01268 754429 | Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Terms and Conditions